Antineoplastic Activity of Metformin
Nov 30, 2019
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Andrew Daoud, PharmD Candidate, Florida A&M University
Conflicting findings on metformin’s possible relationship to cancer.
Researchers have explored the use of glucose-lowering medications (GLMs) and the ability to reduce the risk of cancer. Metformin is used in the treatment of patients with diabetes and is known to have a good safety profile. The majority of studies conducted on metformin or other GLMs and their effect on cancer risk are not conclusive, with studies having heterogeneous results....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.